| Nicholas Villalobos, | |
|
Msc10 5550, I University Of New Mexico, Albuquerque, NM 87131-0001 | |
| (505) 272-4661 | |
| Not Available |
| Full Name | Nicholas Villalobos |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | Msc10 5550, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841677069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | T9813 (Texas) | Primary |
| Entity Name | Cogent Healthcare Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20061121000364 |
News Archive
Mylan Inc. today confirmed that Mylan Pharmaceuticals Inc. and Orion Corporation have entered into a settlement and license agreement settling the parties litigation in connection with Mylan's filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Carbidopa/Levodopa/Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg.
Three primary care organizations have today been announced as joint winners of a competition to enable healthcare professionals to offer free access to an award-winning behavior change platform, the Low Carb Program, for a select group of their patients living with Type 2 diabetes.
Targeted Genetics Corporation (the "Company") today announced that it has completed the technology transfer portion of the September 2009 asset sale transaction executed between the Company and Genzyme Corporation ("Genzyme") and has received the full $7.0 million provided for in the asset purchase agreement.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
As the United States confronts the growing epidemic of obesity among children and adults, a team of University of Colorado School of Medicine obesity researchers concludes that what the nation needs is a new battle plan - one that replaces the emphasis on widespread food restriction and weight loss with an emphasis on helping people achieve "energy balance" at a healthy body weight.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas - Dallas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164174124 PECOS PAC ID: 3678966819 Enrollment ID: O20220210000709 |
News Archive
Mylan Inc. today confirmed that Mylan Pharmaceuticals Inc. and Orion Corporation have entered into a settlement and license agreement settling the parties litigation in connection with Mylan's filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Carbidopa/Levodopa/Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg.
Three primary care organizations have today been announced as joint winners of a competition to enable healthcare professionals to offer free access to an award-winning behavior change platform, the Low Carb Program, for a select group of their patients living with Type 2 diabetes.
Targeted Genetics Corporation (the "Company") today announced that it has completed the technology transfer portion of the September 2009 asset sale transaction executed between the Company and Genzyme Corporation ("Genzyme") and has received the full $7.0 million provided for in the asset purchase agreement.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
As the United States confronts the growing epidemic of obesity among children and adults, a team of University of Colorado School of Medicine obesity researchers concludes that what the nation needs is a new battle plan - one that replaces the emphasis on widespread food restriction and weight loss with an emphasis on helping people achieve "energy balance" at a healthy body weight.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Villalobos, Msc10 5550, I University Of New Mexico, Albuquerque, NM 87131-0001 Ph: () - | Nicholas Villalobos, Msc10 5550, I University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (505) 272-4661 |
News Archive
Mylan Inc. today confirmed that Mylan Pharmaceuticals Inc. and Orion Corporation have entered into a settlement and license agreement settling the parties litigation in connection with Mylan's filing of an Abbreviated New Drug Application with the U.S. Food and Drug Administration for Carbidopa/Levodopa/Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg.
Three primary care organizations have today been announced as joint winners of a competition to enable healthcare professionals to offer free access to an award-winning behavior change platform, the Low Carb Program, for a select group of their patients living with Type 2 diabetes.
Targeted Genetics Corporation (the "Company") today announced that it has completed the technology transfer portion of the September 2009 asset sale transaction executed between the Company and Genzyme Corporation ("Genzyme") and has received the full $7.0 million provided for in the asset purchase agreement.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
As the United States confronts the growing epidemic of obesity among children and adults, a team of University of Colorado School of Medicine obesity researchers concludes that what the nation needs is a new battle plan - one that replaces the emphasis on widespread food restriction and weight loss with an emphasis on helping people achieve "energy balance" at a healthy body weight.
› Verified 1 days ago
Dr. Alberto Aguayo Rico, M.D, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 San Mateo Blvd Se, Albuquerque, NM 87108 Phone: 505-462-7333 Fax: 505-462-7440 | |
Peter Guido, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Jefferson St Ne, Ste 800, Albuquerque, NM 87109 Phone: 505-872-6000 Fax: 505-872-6003 | |
Kenneth A Bell, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Transport St Se, Albuquerque, NM 87106 Phone: 505-262-7110 Fax: 505-262-7308 | |
Joseph F. Oser, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
Dr. Stanley Zissman Berman, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 7416 Vista Del Arroyo Ave Ne, Albuquerque, NM 87109 Phone: 505-884-7270 | |
Huyentrang Vu, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Tamara Goodman, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 |